PeriVision
Easy access to glaucoma care through an innovative portable, fast and easy-to-use Virtual Reality headset supported by visual field testing software to measure glaucoma progression.
PeriVision has raised €4.1M across 2 funding rounds from 12 investors, most recently a Seed round in Sep 2025. Based in Bern, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.1M
€4,067,669
Funding rounds
2
Investors
12
distinct backers
Active since
2021-12
latest 2025-09
Funding by year
EUR raised per yearPeriVision — funding by year — interactive chart.
Data table
| PeriVision — funding by year | |
|---|---|
| 2021 | €1.5M |
| 2025 | €2.6M |
Signals
High confidenceRaise-next likelihood70
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-12 | Seed | €2.6M | Arya VC,CADFEM,Dart Ventures,InaTec,Is Bank’s AI Factory,Juchum Foundation+5 more | View deal → |
| 2021-12-21 | Other | €1.5M | EIT Health | View deal → |
Investors
12Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData